Novo Nordisk, the drugmaker behind Ozempic and other weight loss and diabetes drugs, said it would cut 9,000 jobs
as it seeks to lower costs and revitalize growth.
Source: X
Share this:
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.